Cosmax Inc (192820)
Korea Stock Exchange · Korea · prices in KRW · close of 22 Oct 2026
Key indicators
| Last close | KRW 272,500.00 |
|---|---|
| 52-week range | 141,000.00 – 320,000.00 |
| Return, 1 month / 3 months | +0.9% / +61.1% |
| Return, 1 year / 3 years | +32.8% / +121.3% |
| Trend | Uptrend |
| RSI (14) | 47 |
| Volatility (1 year) | 56.1% |
| Worst drawdown (1 year) | -36.2% |
| Average daily value traded | 34,116.36M KRW |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cosmax is a Korean cosmetics company that develops and manufactures skincare and makeup products for other brands, working as an original design manufacturer. It handles formulation, packaging and production for a wide range of cosmetics labels, and it also makes health-functional foods and some of its own branded goods. Its customers include domestic and overseas beauty brands that rely on it to turn product ideas into finished items. The company is based in Korea.
Cosmax Inc trades under the code 192820 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cosmax Inc (192820) trades on the Korea Stock Exchange in Korea. It last closed at KRW 272,500.00 on 22 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 33 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.8% and over the last three months it rose 61.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 97 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 32.6% | ||
| From 52-week high | -11.7% | ||
| Momentum | 93 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 61.1% | ||
| 6-month return | 25.3% | ||
| 12-month return, skipping the last month | 31.6% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 56.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.2% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 34,116.36M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 35 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | +0.9% |
| 3 months | +61.1% |
| 6 months | +25.3% |
| 1 year | +32.8% |
| 3 years | +121.3% |
| 5 years | +118.5% |
Signals
| 50-day / 200-day average | 272,240.00 / 205,520.44 |
|---|---|
| Golden / death cross (60 days) | Golden, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17,153.87 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 3,300.0000 |
| 27 Dec 2024 | KRW 2,300.0000 |
| 27 Dec 2023 | KRW 500.0000 |
| 28 Dec 2022 | KRW 550.0000 |
| 29 Dec 2021 | KRW 550.0000 |
| 29 Dec 2020 | KRW 915.9633 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.